Skip to main content

ICE MAKE’s In-House Manufacturing Plant Commissioned at Gandhinagar


Ice Make Refrigeration Limited (Ice Make), one of the leading manufacturer & supplier of cooling solutions equipment, has commissioned its in-house manufacturing facility of condenser coil and evaporator coil at Dantali, Gandhinagar, Gujarat. The Company in December 2017 raised Rs 24 crore through initial public offer to part finance setting up this plant, backward integration to improve production efficiencies and upgradation of existing facilities at its plants in Gujarat and Tamil Nadu.


Mr Chandrakant P. Patel, Chairman and Managing Director, Ice Make Refrigeration Limited said “The condenser coils and the evaporator coils are an essential component of the condenser and evaporator respectively, which are integrated into the refrigeration equipment. The Company earlier had to procure condenser coil from the domestic market and majority of suppliers of evaporator coil from overseas. But now with the commissioning of this in-house manufacturing facility with a capacity of 45000 units and up-gradation of various machines at our existing plants we have efficiently improved our production efficiencies reduced lead time in procurements and as well as reduced inventory carrying costs. As planned we have upgraded the existing facilities by Installing Laser Cutting Machine, Upgrading the PUF foaming technologies, adding new models of Bulk Milk Chillers and carried other ancillary improvements in the system assembly”

The company is currently supported by two state-of-the art manufacturing facilities speared across 2, 45,000 square feet of land area at Dantali, Gujarat and 20,000 square feet of land area in Chennai, Tamil Nadu. The Company manufactures Cold Rooms, Refrigeration Systems, Cold room doors, Mobile Refrigeration Vans, Chiller, Ice building Tank, Deep Freezer, Bulk Milk chiller systems, Hose Chiller, Ice candy Machine among other cooling equipments.  These refrigeration products are used by wide range of Industries including Dairy, Ice Cream, food processing, agriculture, pharmaceuticals, Cold Chain, Logistics, hospitals, Hospitality and retail among others. 


Ice Make Refrigeration Limited has been successfully satisfying the needs of its customers, from production to aftersales service, since 1993. The Company is engaged in the business of providing customized cooling solutions to diverse set of clients across wide range of industries by manufacturing and supply of high quality refrigeration products& equipment. The Company operates under key business verticals including Cold Room, Commercial Refrigeration, Industrial Refrigeration, Transport Refrigeration & newly added ammonia refrigeration and caters to wide range of Industries in India and also exports its products to overseas clients in 21 countries. 

Ice Make was listed on NSE Emerge on December 8, 2017. The Company attracted record SMEIPO subscription of over 261 times, worth over 6100 Crores. The Company over the years have received several awards and accolades including Indian Leadership Award for Industrial Development in 2011, Best Medium Enterprise (Manufacturing) by Canara Bank & Skoch Award in 2014, India SME 100Award in 2017 and Gold Award for excellence within its core industry category & 2017-18 Vision Award for Annual Report Competition” hosted by the League of American Communications Professionals LLC (LACP) where ICE Make has been ranked 27th among the top 100 annual reports globally.


Location: Gandhinagar, Gujarat, India

Comments

Post a Comment

Popular posts from this blog

Smallcase Platform: 2025 Wealth Creation Strategies to Achieve Your Investment Goals

  By Dr. Vikas Gupta, CEO and Chief Investment Strategist, OmniScience Capital In the intricate world of finance, wealth creation is a universal aspiration among investors, though few truly attain it. With a plethora of investment products, philosophies, and strategies available, the challenge is identifying an approach that not only offers returns but also minimizes risk. At OmniScience Capital, we believe the key to successful wealth creation lies in a scientific and disciplined investment strategy. Our unique offerings, rooted in the principles of Scientific Investing, are designed to help you achieve your financial goals with confidence. Pioneering Global Investing and Outperforming on Smallcase Platform OmniScience Capital, a global investment management firm specializing in global and Indian equities, is a pioneer in global investing and growth vectors such as Defense and Digital Transformation. Our strategies have consistently identified and capitalized on growth vectors tha...
Post a Comment
Read more

Country Delight Launches NMR-Tested Honey: The Gold Standard of Purity

  Country Delight continues strengthening its promise of delivering the best purity and quality by launching 100% Pure Farm Honey (NMR Tested) Country Delight, a trusted name in premium and natural essentials, has announced the launch of 100% Pure Farm Honey (NMR Tested). Country Delight’s Farm Honey is Nuclear Magnetic Resonance (NMR) tested by a certified lab in Germany, making it one of the most authentic and reliable kitchen ingredients available to Indian homes. It also undergoes rigorous testing on 36 quality parameters as per FSSAI standards, including physicochemical, antibiotic and microbial, to rule out the presence of added sugars. Honey is not just a natural sweetener; it is increasingly valued for its functional benefits. With Country Delight's NMR-tested honey, consumers can enjoy a product that supports wellness through its natural composition, which is rich in antioxidants and phytonutrients and offers advantages over refined sugars.  Adulteration with cheaper ...
Post a Comment
Read more

Prachay Capital’s Public Issue of Secured NCDs Fully Subscribed at 113.36%

Prachay Capital Limited, an RBI-registered Non-Banking Financial Company – Investment and Credit Company (NBFC-ICC), has successfully closed its public issue of Secured, Rated, Redeemable Non-Convertible Debentures (NCDs) at 113.36% subscription, according to exchange data. The issue, which opened on February 28, 2025, on the Bombay Stock Exchange (BSE), aimed to raise Rs 50 crore (excluding the greenshoe option) and closed on March 13, 2025. With a BSE listing, this issue was open for subscription to retail investors, high-net-worth individuals (HNIs), institutional investors, and corporates. The maiden NCDs issue is scheduled to list on 24 March 2025.  Rated BBB-/Stable by CRISIL, these NCDs offer investors a 13% per annum return with monthly interest payouts, making them an attractive fixed-income opportunity. The proceeds will be deployed as per the company’s stated fund allocation plan. Fund Utilization: Minimum 75% for the purpose of onward lending, investments in current and...
Post a Comment
Read more